3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Lymphoma, Non-Hodgkin
20
Leukemia, Myeloid, Acute
11
Hodgkin Disease
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myelodysplastic Syndromes
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Gliosarcoma
3
Glioblastoma
3
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Glioma
2
Burkitt Lymphoma
2
Warts
1
Waldenstrom Macroglobulinemia
1
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
plerixafor
×
Clear all
No trials found.